Last Price
2.54
Today's Change
+0.71 (38.79%)
Day's Change
2.35 - 3.37
Trading Volume
63,228,242
Profile
ZVSA
Exchange: NASDAQ Global Market NASDAQ Global Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Mr. Stephen C. Glover Mr. Stephen C. Glover
Full Time Employees: 7 7
IPO Date: 2022-02-11 2022-02-11
CIK: 0001859007 0001859007
ISIN: US98987D2018 US98987D2018
Beta: 0.64 0.64
Last Dividend: 0.00 0.00
Dcf Diff: 1.78 1.78
Dcf: 3.21 3.21
Description
ZyVersa Therapeutics, Inc., a clinical stage biopharmaceutical company, develops and commercializes products for the treatment of renal and inflammatory diseases. It engages in the development of VAR 200, a cholesterol efflux mediator to treat focal segmental glomerulosclerosis, alport syndrome, and diabetic kidney disease; and IC 100, a novel inflammasome ASC inhibitor for treatment of multitude of inflammatory diseases. ZyVersa Therapeutics, Inc. is headquartered in Weston, Florida.
Address
Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment
Featured Posts
12
Apps
Top Articles
1
CEO Morning Brief
Bitcoin Traders Brace for Fierce Price Swings as Clock Ticks to US Vote
2
CEO Morning Brief
Oil Gains 3% After Opec+ Delays Output Hike, US Election in Focus
3
4
CEO Morning Brief
Trump's Tariffs Would Reorder Trade Flows, Raise Costs, Draw Retaliation
5
CEO Morning Brief
Rock-steady Rupee Offers Stability During US Election Uncertainty
#
Stock
Score
Daily Stocks
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Stock
Last
Change
Volume
Ride The Bull Short The Bear
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
